VRTX position history
The shares of Vertex Pharmaceuticals (VRTX) that TORRAY INVESTMENT PARTNERS LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2023 Q4: 14,068 shares, $5.7M, 0.93% of portfolio, New
- 2024 Q1: 37,601 shares, $12M, 1.7% of portfolio, Add +167.3%
- 2024 Q2: 13,938 shares, $6.5M, 0.98% of portfolio, Reduce −62.9%
- 2024 Q3: 15,751 shares, $7.3M, 1.0% of portfolio, Add +13.0%
- 2024 Q4: 16,008 shares, $6.4M, 0.92% of portfolio, Add +1.6%
- 2025 Q1: 15,721 shares, $7.6M, 1.1% of portfolio, Reduce −1.8%
- 2025 Q2: 16,879 shares, $7.5M, 1.1% of portfolio, Add +7.4%
- 2025 Q3: 16,255 shares, $6.4M, 0.86% of portfolio, Reduce −3.7%
- 2025 Q4: 15,466 shares, $7M, 1.0% of portfolio, Reduce −4.9%
- 2026 Q1: 15,386 shares, $6.9M, 1.0% of portfolio, Reduce −0.5%
- 2026 Q2: 15,215 shares, $7.6M, 1.0% of portfolio, Reduce −1.1%
- 2026 Q3: not held, Exit
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|